UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients.

[1]  Daxesh P. Patel,et al.  Simultaneous quantification of atenolol and chlorthalidone in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry. , 2016, Biomedical chromatography : BMC.

[2]  I. Panderi,et al.  Direct injection human plasma analysis for the quantification of antihypertensive drugs for therapeutic drug monitoring using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Jialang Zhuang,et al.  Validation of a HPLC-ESI MS/MS method for the determination of clonidine in human plasma and its application in a bioequivalence study in Chinese healthy volunteers. , 2015, Biomedical chromatography : BMC.

[4]  G. Buszewicz,et al.  Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization , 2015, Acta pharmaceutica.

[5]  N. Sheth,et al.  Development and validation of bioanalytical method for simultaneous estimation of ramipril and hydrochlorothiazide in human plasma using liquid chromatography-tandem mass spectrometry. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  S. Khoo,et al.  No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals. , 2014, AIDS.

[7]  C. Ayers,et al.  Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. , 2014, Journal of the American College of Cardiology.

[8]  M. Burnier,et al.  State-of-the-art treatment of hypertension: established and new drugs. , 2014, European heart journal.

[9]  Ji Jiang,et al.  Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  S. Laurent,et al.  True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence , 2013, Journal of hypertension.

[11]  J. Urquhart,et al.  Measuring, analyzing, and managing drug adherence in resistant hypertension. , 2013, Hypertension.

[12]  Jeroen J. Bax,et al.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2013, European heart journal.

[13]  Daxesh P. Patel,et al.  Highly sensitive and rapid ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of nifedipine in human plasma and its application to a bioequivalence study. , 2012, Biomedical chromatography : BMC.

[14]  Ş. Arslan,et al.  HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey. , 2012, Journal of chromatographic science.

[15]  Yan Zhu,et al.  Fast gradient high performance liquid chromatography method with UV detection for simultaneous determination of seven angiotensin converting enzyme inhibitors together with hydrochlorothiazide in pharmaceutical dosage forms and spiked human plasma and urine. , 2011, Talanta.

[16]  Feng Qin,et al.  Determination of nifedipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  V. Gupta,et al.  Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry. , 2011, Talanta.

[18]  Dongyang Liu,et al.  Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  J. P. Fawcett,et al.  Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma. , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  Kang-Choon Lee,et al.  Quantification of doxazosin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. , 2008, Journal of separation science.

[21]  F. Veglio,et al.  Characteristics of the patients referred to a Hypertension Unit between 1989 and 2003 , 2008, Journal of Human Hypertension.

[22]  Dongyang Liu,et al.  Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[24]  Feng Qin,et al.  Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.

[25]  A. Dominiczak,et al.  2007 ESH‐ESC Guidelines for the management of arterial hypertension , 2007 .

[26]  Y. Choi,et al.  High-performance liquid chromatographic determination of doxazosin in human plasma for bioequivalence study of controlled release doxazosin tablets. , 2006, Biomedical chromatography : BMC.

[27]  A. Zarghi,et al.  Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies. , 2005, Farmaco.

[28]  P. Taylor.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. , 2005, Clinical biochemistry.

[29]  L. Neirinck,et al.  Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  S. Atmaca,et al.  Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[31]  D. Calhoun,et al.  Resistant hypertension: incidence, prevalence, and prognosis. , 2012, Circulation.

[32]  J. Ceral,et al.  Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy , 2011, Hypertension Research.

[33]  Daniel W. Jones,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.